Aili Guo, M.D.

Aili Guo, M.D.


Endocrinology, Diabetes, and Metabolism


  • Associate Professor


To see if Aili Guo is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Medical Group - Sacramento (Campus Commons)

500 University Avenue, Ste. 220
Sacramento, CA 95825
Driving Directions

Primary Phone:

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 0400
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Clinic Phone: 916-286-8700
Clinic Phone: 916-734-2737
Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Clinical Interests

Dr. Guo is a board certified adult endocrinologist with extensive clinical experience in management of thyroid and parathyroid disease, pituitary and adrenal disease, diabetes mellitus, and other metabolic disorders. She has special clinical interest and expertise in thyroid disease, adrenal disease, and diabetes mellitus.


Endocrinology, Diabetes, and Metabolism

Center/Program Affiliation

UC Davis Medical Group


M.D., Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing China 1989

B.S., Sun Yat-Sen University of Medical Sciences, Guangzhou China 1983

Internship: Internal Medicine, University of Wisconsin School of Medicine, Milwaukee WI 2004-2005


Internal Medicine, University of Utah School of Medicine, Salt Lake City UT 2005-2007


Endocrinology & Diabetes, University of Utah School of Medicine, Salt Lake City UT 2007-2010

Board Certifications

American Board of Internal Medicine,

American Board of Internal Medicine, Endocrinology,

Professional Memberships

American Academy of Clinical Endocrinologists (AACE)

American Diabetes Association

American Thyroid Association

The Endocrine Society

Select Recent Publications

Guo A, Kaminoh Y, Forward T, Schwartz, FL and Jenkinson S. Fine Needle Aspiration of Thyroid Nodules Using the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience in a Rural Setting. International Journal of Endocrinology 2017; 2017:1-6

Guo A, Daniels NA, Thuma J, McCall KD, Malgor R, et al. Diet is critical for prolonged glycemic control after short-term insulin treatment in high-fat diet-induced type 2 diabetic male mice. PLoS ONE. 2015; 10(1):1-16

Slepchenko KG, Daniels NA, Guo A, Li YV. Autocrine effect of Zn2+ on the glucose-stimulated insulin secretion. Endocrine. 2015; 50(1):110-122

Wende AR, O'Neill BT, Bugger H, Riehle C, Tuinei J, Buchanan J, Tsushima K, Wang L, Caro P, Guo A, Sloan C, Kim BJ, Wang X, Pereira RO, McCrory MA, Nye BG, Benavides GA, Darley-Usmar VM, Shioi T, Weimer BC, Abel ED. Enhanced cardiac Akt/protein kinase B signaling contributes to pathological cardiac hypertrophy in part by impairing mitochondrial function via transcriptional repression of mitochondrion-targeted nuclear genes. Molecular and Cellular Biology. 2015; 35(5):831- 846

Shubrook JH, Becerra NM, Adkins SE, Guo AL. Insulin: a 2014 primer, Part 1-2. Primary care reports 2014: 20(8):89-98; 2014: 20(9):101-110

Schwartz FL, Guo A, Marling CR, Shubrook JH. Analysis of use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in type 1 diabetes mellitus patients treated with multiple daily insulin injections. Journal of Diabetes Science and Technology. 2012; 6(1):150-152

Shubrook J, Colucci R, Guo A, Schwartz F. Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus. Clinical medicine insights. Endocrinology and Diabetes. 2011; 4:1-12

O'Neill BT, Kim J, Wende AR, Theobald HA, Tuinei J, Buchanan J, Guo A, et al. A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metabolism. 2007; 6(4):294-306